Kimura Kazumi, Iguchi Yasuyuki, Shibazaki Kensaku, Aoki Junya, Terasawa Yuka
Department of Stroke Medicine, Kawasaki Medical School, Japan.
J Neurol Sci. 2008 Sep 15;272(1-2):136-42. doi: 10.1016/j.jns.2008.05.012. Epub 2008 Jul 7.
Symptomatic intracranial hemorrhages are typically clinically catastrophic and occur more frequently with tissue plasminogen activator (t-PA) therapy compared to without t-PA therapy. However, it has been unclear whether asymptomatic intracranial hemorrhage has clinical implications.
Consecutive anterior-circulation ischemic stroke patients treated with t-PA within 3 h of stroke onset were studied prospectively. Patients with symptomatic hemorrhages were excluded from the study. To identify the presence of early recanalization and intracranial hemorrhage, as well as to measure infarction volume, MRI examinations, including diffusion-weighted imaging, T2(), FLAIR, and MRA, were performed before and 1 h, 24 h, and 5-7 days after t-PA thrombolysis. At the same time, serial NIHSS scores were obtained. The independent predictors of dramatic recovery were determined using multivariate logistic regression analysis.
51 patients were enrolled in the present study. 22 patients (H group) had an asymptomatic hemorrhage. The NIHSS score of the Non-H group decreased, but that of the H group did not (11.5+/-6.5 vs. 17.1+/-6.5 at baseline, and 4.5+/-6.8 vs. 14.3+/-7.6 at 7 days; P=0.0073 for ANOVA). Asymptomatic hemorrhage was more frequently seen in non-dramatic improvement group than in dramatic improvement group (65.5% vs. 13.6%, P=0.0002). On multivariate logistic regression analysis using the variables that had a P<0.1 on univariate analysis (AF, baseline NIHSS score, glucose, the presence of asymptomatic hemorrhage, ICA occlusion, early recanalization 1 h after t-PA infusion, and infarction volume 7 days after t-PA therapy), early recanalization (OR: 11.33; 95%CI: 1.064-120.704; P=0.044) and infarction volume <100 cm(3) (OR: 13.56; 95%CI: 1.020-180.125; P=0.048) were independent factors for dramatic improvement, while asymptomatic hemorrhage (OR: 0.03; 95%CI: 0.002-0.537; P=0.016) was an independent negative factor.
Asymptomatic hemorrhage was an independent negative factor for dramatic improvement. Asymptomatic hemorrhage after t-PA thrombolysis may be associated with neurological recovery.
有症状的颅内出血通常在临床上具有灾难性,与未使用组织型纤溶酶原激活剂(t-PA)治疗相比,t-PA治疗时其发生频率更高。然而,无症状颅内出血是否具有临床意义尚不清楚。
对卒中发作3小时内接受t-PA治疗的连续性前循环缺血性卒中患者进行前瞻性研究。有症状性出血的患者被排除在研究之外。为了确定早期再通和颅内出血的存在,以及测量梗死体积,在t-PA溶栓前、溶栓后1小时、24小时和5 - 7天进行了MRI检查,包括弥散加权成像、T2()、液体衰减反转恢复序列(FLAIR)和磁共振血管造影(MRA)。同时,获得了美国国立卫生研究院卒中量表(NIHSS)的系列评分。使用多因素逻辑回归分析确定显著恢复的独立预测因素。
本研究共纳入51例患者。22例患者(H组)有无症状性出血。非H组的NIHSS评分下降,但H组未下降(基线时分别为11.5±6.5和17.1±6.5,7天时分别为4.5±6.8和14.3±7.6;方差分析P = 0.0073)。无症状性出血在非显著改善组比在显著改善组更常见(65.5%对13.6%,P = 0.0002)。在对单因素分析中P<0.1的变量(房颤、基线NIHSS评分、血糖、无症状性出血的存在、颈内动脉闭塞、t-PA输注后1小时早期再通以及t-PA治疗7天后的梗死体积)进行多因素逻辑回归分析时,早期再通(比值比:11.33;95%置信区间:1.064 - 120.70;P = 0.044)和梗死体积<100 cm³(比值比:13.56;95%置信区间:1.020 - 180.125;P = 0.048)是显著改善的独立因素,而无症状性出血(比值比:0.03;95%置信区间:0.002 - 0.537;P = 0.016)是独立的负性因素。
无症状性出血是显著改善的独立负性因素。t-PA溶栓后的无症状性出血可能与神经功能恢复相关。